Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ya-Hui Chi

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Bioorganic & Medicinal Chemistry|October 22, 2023
Analysis of structure-activity relationship of indol-3-yl-N-phenylcarbamic amides as potent STING inhibitorsPo-Wei Chang, Jing-Ya Wang, Wan-Ping Wang, et al.
Ebiomedicine|July 3, 2015
Large Isoform of Mammalian Relative of DnaJ is a Major Determinant of Human Susceptibility to HIV-1 InfectionYu-Ping Chiang, Wang-Huei Sheng, Pei-Lan Shao, et al.
Protein Science : a Publication of the Protein Society|April 23, 2002
Oligomerization of acidic fibroblast growth factor is not a prerequisite for its cell proliferation activityAlphonse I Arunkumar, Thallampuranam Krishnaswamy S Kumar, Karuppanan Muthusamy Kathir, et al.
Plos One|July 7, 2012
14-3-3σ regulates β-catenin-mediated mouse embryonic stem cell proliferation by sequestering GSK-3βTzu-Ching Chang, Chia-Chia Liu, En-Wei Hsing, et al.
European Journal of Medicinal Chemistry|April 16, 2018
Design and synthesis of BPR1K653 derivatives targeting the back pocket of Aurora kinases for selective isoform inhibitionYi-Yu Ke, Chun-Ping Chang, Wen-Hsing Lin, et al.
Molecular Cancer Therapeutics|April 9, 2024
Discovery of a Long Half-Life AURKA Inhibitor to Treat MYC-Amplified Solid Tumors as a Monotherapy and in Combination with EverolimusChun-Ping Chang, Teng-Kuang Yeh, Chiung-Tong Chen, et al.
Journal of Medicinal Chemistry|May 19, 2021
Discovery and Synthesis of a Pyrimidine-Based Aurora Kinase Inhibitor to Reduce Levels of MYC OncoproteinsYa-Hui Chi, Teng-Kuang Yeh, Yi-Yu Ke, et al.
Journal of Medicinal Chemistry|July 2, 2013
Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine Aurora kinase inhibitorHui-Yi Shiao, Mohane Selvaraj Coumar, Chun-Wei Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 24, 2013
Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubulesJiun-Ming Wu, Chiung-Tong Chen, Mohane Selvaraj Coumar, et al.
Journal of Medicinal Chemistry|February 27, 2025
Orally Bioavailable and Site-Selective Covalent STING Inhibitor Derived from a Macrocyclic Marine DiterpenoidGuang-Hao Niu, Wan-Chi Hsiao, Po-Hsun Lee, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Bioorganic & Medicinal Chemistry|October 22, 2023
Analysis of structure-activity relationship of indol-3-yl-N-phenylcarbamic amides as potent STING inhibitorsPo-Wei Chang, Jing-Ya Wang, Wan-Ping Wang, et al.
Ebiomedicine|July 3, 2015
Large Isoform of Mammalian Relative of DnaJ is a Major Determinant of Human Susceptibility to HIV-1 InfectionYu-Ping Chiang, Wang-Huei Sheng, Pei-Lan Shao, et al.
Protein Science : a Publication of the Protein Society|April 23, 2002
Oligomerization of acidic fibroblast growth factor is not a prerequisite for its cell proliferation activityAlphonse I Arunkumar, Thallampuranam Krishnaswamy S Kumar, Karuppanan Muthusamy Kathir, et al.
Plos One|July 7, 2012
14-3-3σ regulates β-catenin-mediated mouse embryonic stem cell proliferation by sequestering GSK-3βTzu-Ching Chang, Chia-Chia Liu, En-Wei Hsing, et al.
European Journal of Medicinal Chemistry|April 16, 2018
Design and synthesis of BPR1K653 derivatives targeting the back pocket of Aurora kinases for selective isoform inhibitionYi-Yu Ke, Chun-Ping Chang, Wen-Hsing Lin, et al.
Molecular Cancer Therapeutics|April 9, 2024
Discovery of a Long Half-Life AURKA Inhibitor to Treat MYC-Amplified Solid Tumors as a Monotherapy and in Combination with EverolimusChun-Ping Chang, Teng-Kuang Yeh, Chiung-Tong Chen, et al.
Journal of Medicinal Chemistry|May 19, 2021
Discovery and Synthesis of a Pyrimidine-Based Aurora Kinase Inhibitor to Reduce Levels of MYC OncoproteinsYa-Hui Chi, Teng-Kuang Yeh, Yi-Yu Ke, et al.
Journal of Medicinal Chemistry|July 2, 2013
Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine Aurora kinase inhibitorHui-Yi Shiao, Mohane Selvaraj Coumar, Chun-Wei Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 24, 2013
Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubulesJiun-Ming Wu, Chiung-Tong Chen, Mohane Selvaraj Coumar, et al.
Journal of Medicinal Chemistry|February 27, 2025
Orally Bioavailable and Site-Selective Covalent STING Inhibitor Derived from a Macrocyclic Marine DiterpenoidGuang-Hao Niu, Wan-Chi Hsiao, Po-Hsun Lee, et al.
Pageof 5